P2Y12 Inhibitor Pretreatment in Non-ST-Segment Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry
The NCDR Chest Pain-MI registry demonstrated significant variability in the administration of P2Y12 inhibitors before coronary angiography in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) across hospitals and operators. The presence or absence of pretreatment did not affect in-hospital mortality or MI incidence, but in patients who underwent CABG, P2Y12 inhibitor pretreatment was associated with a longer hospital stay, Dr. Hiroki A. Ueyama and colleagues, Emory University School of Medicine, USA, reported in the February 4 issue of the Journal of the American College of Cardiology.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
